GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2016-2024

  • You are here:
  • Home
  • Reports
  • GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2016-2024

GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2016-2024

GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2016-2024

Request free sample

The global allergy diagnostic and treatment market is worth $36.35 billion in 2016 and is expected to grow at a healthy CAGR of 5.5% to $55.77 billion by 2024. The base year considered is 2015 and the forecast period is from 2016-2024. The allergy diagnostic and treatment market is lucrative and has potential to grow due to growth in allergies globally, higher healthcare expenditure and increase in pollution and urbanization.

The global allergy diagnostic and treatment market is worth $36.35 billion in 2016 and is expected to grow at a healthy CAGR of 5.5% to $55.77 billion by 2024. The base year considered is 2015 and the forecast period is from 2016-2024. The allergy diagnostic and treatment market is lucrative and has potential to grow due to growth in allergies globally, higher healthcare expenditure and increase in pollution and urbanization.

According to the World Allergy Organization (WAO), between 30% and 40% of the world’s population is affected by one or more allergic conditions. Allergy testing can be done through skin prick, subcutaneous or patch analysis, provocation testing, or blood analysis. The standard diagnostic tool is the skin test, but industry representatives believe there is a substantial and growing market for blood analysis testing.

allergy diagnostics market

On the basis of the type of test, global allergy diagnostic and treatment market is segmented into skin testing and antibody. The most prevalent type of allergy testing remains skin prick or scratch or puncture tests. Skin testing holds a large share in the market and is expected to continue its dominance during the forecast period. A skin test requires 15 minutes to 20 minutes to determine the allergen which is affecting the patient. Allergen blood tests or enzyme immunoassays (EIAs) are based on the measurement of total IgE and specific IgE antibodies that react with extracts from allergenic substances. These tests are sometimes used when a patient is on some medication which might interfere with skin testing or has some skin problems.

On the basis of the mode of availability for treatment, global allergy diagnostic and treatment market is segmented into “prescription” and “over the counter”. Prescription drugs are head to head with OTC drugs as consumers prefer treatment by OTC instead of a proper treatment by prescriptions as they show their effect quickly. Prescription treatment requires a patient to continue medication for a longer period in order to reduce the allergens and soothe theallergy. However, when treatment is stopped, the allergy reoccurs. Many patients suffering from allergy have found that OTC products work just as well as some prescription or generic products in relieving symptoms of allergies.

Geographically, the global allergy diagnostic and treatment market is segmented into Americas, Europe, APAC and Rest of World. Americas hold the largest share in the market and are expected to continue their dominance during the forecast period. The rapidly expanding market in Brazil is driving the South American region whereas the U.S. market is a huge market in Central America. The region is primarily driven by the rising pollution, increasing prevalence of allergic diseases, and increasing population.

High incidences and large economic burden of allergic diseases, increase in access to medical insurance in the U.S, increasing healthcare expenditure, and rising environmental pollution are some of the major drivers for growth in global allergy diagnostic and treatment market. Additionally, economic growth in developing countries, access to health care products by individuals who had no prior access, changes in dietary habits, better diagnostics of allergy problems, and structural changes in health care systems are all contributing to the growth of the global allergy diagnostic and treatment market.

The major players in the allergy diagnostics market are Hitachi Chemical Diagnostics Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Siemens AG, HYCOR Biomedical, Stallergenes Greer, and Lincoln Diagnostics Inc.

  1. RESEARCH SCOPE
    • MARKET DEFINITION
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • PRIMARY SOURCES
      • SECONDARY SOURCES
    • MARKET SIZE ESTIMATION
    • DATA TRIANGULATION
    • ASSUMPTIONS
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
  4. MARKET OVERVIEW
    • MARKET DRIVERS
      • HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
      • RISING ENVIRONMENTAL POLLUTION
      • INCREASING HEALTHCARE EXPENDITURE
      • INCREASE IN ACCESS TO MEDICAL INSURANCE IN THE U.S.
    • MARKET RESTRAINTS
      • STRINGENT REGULATIONS FOR MEDICAL DEVICES
      • LACK OF AWARENESS ABOUT ALLERGIC DISEASES
      • HIGH CAPITAL REQUIREMENTS
      • HIGH DEGREE OF CONSOLIDATION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS
    • MARKET OPPORTUNITIES
      • ASIAN MARKET PRESENTS HIGH-GROWTH OPPORTUNITIES
  1. DEVELOPMENTS IN ALLERGY TESTING AND TREATMENT
    • NEW DEVELOPMENTS IN DIAGNOSTIC TESTING
    • ALLERGEN COMPONENT-RESOLVED DIAGNOSTICS
    • ADVANCES IN TREATMENTS
      • CHINESE HERBAL MEDICINE
      • IMMUNOTHERAPY
      • B CELL EPITOPE-BASED IMMUNOTHERAPY
      • NASAL FILTERS
  1. MARKET SEGMENTATION
    • GLOBAL ALLERGY DIAGNOSTIC MARKET, BY TYPE OF TEST
      • SKIN TESTING
      • ANTIBODY
    • GLOBAL IMMUNOTHERAPY MARKET, BY MODE OF ADMINISTRATION
      • SUBCUTANEOUS ADMINISTRATION
      • SUBLINGUAL LIQUID SOLUTIONS
      • SUBLINGUAL TABLETS
    • GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF AVAILABILITY
      • PRESCRIPTION
      • OVER THE COUNTER (OTC)
    • GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF ADMINISTRATION
      • ORAL
      • SPRAY
      • OCULAR
      • TOPICAL
    • GLOBAL ALLERGY TREATMENT MARKET, BY PRODUCT
      • ANTIHISTAMINES
      • SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS
      • CORTICOSTEROIDS
      • LEUKOTRIENES
      • MAST CELL STABILIZERS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCES
    • PESTEL ANALYSIS
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • AMERICAS
      • UNITED STATES
      • CANADA
      • BRAZIL
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • RUSSIA
      • REST OF EUROPE
    • ASIA-PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA AND NEW ZEALAND
      • REST OF ASIA-PACIFIC (ROAPAC)
    • MIDDLE EAST & AFRICA
  3. COMPETITIVE ANALYSIS
    • MARKET SHARE
    • COMPANY PROFILES FOR DIAGNOSTICS
      • ALERE
      • ALK-ABELLÓ
      • ALLERGY LABORATORIES INC.
      • ALLERGOPHARMA AG
      • ANI BIOTECHNOLOGY
      • BECKMAN COULTER/DANAHER
      • BIOMERICA
      • DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
      • FIRST DIAGNOSTIC LLC
      • GREER HUMAN ALLERGY
      • HAL ALLERGY
      • HOLLISTER-STIER ALLERGY
      • HITACHI CHEMICAL DIAGNOSTICS INC.
      • HYCOR BIOMEDICAL
      • LABCORP OF AMERICA
      • LINCOLN DIAGNOSTICS
      • QUEST DIAGNOSTICS
      • SIEMENS HEALTHCARE
      • SMARTPRACTICE DENMARK
      • TERUMO MEDICAL PRODUCTS
      • THERMO FISHER DIAGNOSTICS (IMMUNODIAGNOSTICS)
    • COMPANY PROFILES FOR TREATMENT
      • ALCON LABORATORIES
      • ALK-ABELLÓ
      • ALLERGEN PHARMACEUTICALS
      • AMEDRA PHARMACEUTICALS LLC
      • AQUA PHARMACEUTICALS
      • FERNDALE PHARMA GROUP (FERNDALE HEALTHCARE)
      • GALDERMA S.A.
      • GLAXOSMITHKLINE
      • JOHNSON & JOHNSON
      • KYOWA HAKKO KIRIN PHARMA INC.
      • LUPIN LTD.
      • MEDA AB
      • MERCK
      • MYLAN INC.
      • PFIZER
      • PIERRE FABRE MEDICAMENT
      • RANBAXY LABORATORIES
      • ROCHE
      • SANDOZ INTERNATIONAL GMBH
      • SANOFI
      • STALLERGENES AS
      • TARO PHARMACEUTICAL INDUSTRIES
      • UCB PHARMA LTD.
  1. APPENDIX
    • PATENTS
    • ABBREVIATIONS AND FULL FORM

 

TABLE LIST

TABLE 1        GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $BILLION)

TABLE 2        GLOBAL SKIN TESTING MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)

TABLE 3        GLOBAL ANTIBODIES MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)

TABLE 4        GLOBAL SUB-CUTANEOUS ADMINISTRATION MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)

TABLE 5        GLOBAL SUBLINGUAL LIQUID SOLUTIONS MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)

TABLE 6        GLOBAL SUBLINGUAL TABLETS MARKET IN ALLERGY DIAGNOSTICS, BY REGION, 2016-2024 (IN $BILLION)

TABLE 7        GLOBAL PRESCRIPTION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 8        GLOBAL OVER THE COUNTER PRODUCTS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 9        GLOBAL ORAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 10      GLOBAL ADMINISTRATION BY SPRAY MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 11      GLOBAL OCULAR ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 12      GLOBAL TOPICAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 13      GLOBAL ANTIHISTAMINES MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 14      GLOBAL SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 15      GLOBAL CORTICOSTEROIDS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 16      GLOBAL LEUKOTRIENES MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)

TABLE 17      GLOBAL MAST CELL STABILIZERS MARKET IN ALLERGY TREATMENT, BY REGION, 2016-2024 (IN $BILLION)
 

FIGURE LIST

FIGURE 1      MARKET SIZE ESTIMATION

FIGURE 2      DATA TRIANGULATION

FIGURE 3      GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $BILLION)

FIGURE 4      GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET SHARE, 2016

FIGURE 5      GLOBAL ALLERGY DIAGNOSTIC MARKET SHARE, BY TYPE OF TEST, 2016

FIGURE 6      GLOBAL SKIN TESTING MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)

FIGURE 7      GLOBAL ANTIBODIES MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)

FIGURE 8      GLOBAL IMMUNOTHERAPY MARKET SHARE, BY MODE OF ADMINISTRATION, 2016

FIGURE 9      GLOBAL SUB-CUTANEOUS ADMINISTRATION MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)

FIGURE 10   GLOBAL SUBLINGUAL LIQUID SOLUTIONS MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)

FIGURE 11   GLOBAL SUBLINGUAL TABLETS MARKET IN ALLERGY DIAGNOSTICS, 2016-2024 (IN $BILLION)

FIGURE 12   GLOBAL ALLERGY TREATMENT MARKET SHARE, BY MODE OF AVAILABILITY, 2016

FIGURE 13   GLOBAL PRESCRIPTION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 14   GLOBAL OVER THE COUNTER PRODUCTS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 15   GLOBAL ALLERGY TREATMENT MARKET SHARE, BY MODE OF ADMINISTRATION, 2016

FIGURE 16   GLOBAL ORAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 17   GLOBAL ADMINISTRATION BY SPRAY MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 18   GLOBAL OCULAR ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 19   GLOBAL TOPICAL ADMINISTRATION MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 20   GLOBAL ALLERGY TREATMENT MARKET SHARE, BY PRODUCT, 2016

FIGURE 21   GLOBAL ANTIHISTAMINES MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 22   GLOBAL SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 23   GLOBAL CORTICOSTEROIDS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 24   GLOBAL LEUKOTRIENES MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 25   GLOBAL MAST CELL STABILIZERS MARKET IN ALLERGY TREATMENT, 2016-2024 (IN $BILLION)

FIGURE 26   GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET SHARE, BY REGION, 2016

FIGURE 27   AMERICAS ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 28   UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 29   CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 30   BRAZIL ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 31   EUROPE, MIDDLE EAST, AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 32   EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 33   GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 34   FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 35   UK ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 36   RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 37   ROE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 38   ASIA-PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024 (IN $BILLION)

FIGURE 39   INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 40   CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 41   JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 42   AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 43   REST OF ASIA-PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 44   MIDDLE EAST ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)

FIGURE 45   AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2016-2024, (IN $ BILLION)
 

  1. MARKET SEGMENTATION
    • GLOBAL ALLERGY DIAGNOSTIC MARKET, BY TYPE OF TEST
      • SKIN TESTING
      • ANTIBODY
    • GLOBAL IMMUNOTHERAPY MARKET, BY MODE OF ADMINISTRATION
      • SUBCUTANEOUS ADMINISTRATION
      • SUBLINGUAL LIQUID SOLUTIONS
      • SUBLINGUAL LIQUID SOLUTIONS
    • GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF AVAILABILITY
      • PRESCRIPTION
      • OVER THE COUNTER (OTC)
    • GLOBAL ALLERGY TREATMENT MARKET, BY MODE OF ADMINISTRATION
      • ORAL
      • SPRAY
      • OCULAR
      • TOPICAL
    • GLOBAL ALLERGY TREATMENT MARKET, BY PRODUCT
      • ANTIHISTAMINES
      • SYMPATHOMIMETICS, DECONGESTANTS, AND COMBINATIONS
      • CORTICOSTEROIDS
      • LEUKOTRIENES
      • MAST CELL STABILIZERS
  1. GEOGRAPHICAL ANALYSIS
    • AMERICAS
      • UNITED STATES
      • CANADA
      • BRAZIL
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • RUSSIA
      • REST OF EUROPE
    • ASIA-PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • AUSTRALIA AND NEW ZEALAND
      • REST OF ASIA-PACIFIC (ROAPAC)
    • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.